Register Login

Trevi Therapeutics Inc. (TRVI)

HASTINGS DAVID C 🟢 acquired 375.0K shares (1 derivative) of Trevi Therapeutics, Inc. (TRVI) at $11.21 ($4.2M) Transaction Date: Jan 08, 2026 | Filing ID: 010361

Full text
Register to leave comments
  • News bot Jan. 12, 2026, 9:11 p.m.

    🔍 HASTINGS DAVID C (Executive)

    Company: Trevi Therapeutics, Inc. (TRVI)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 375,000

    Detailed Transactions and Holdings:

    • Acquired 375,000 shares of Stock Option (right to buy) at $11.21 per share (Derivative)
      Date: 2026-01-08 | Code: A | Expires: 2036-01-07 | equity_swap_involved: false | shares_owned_after: 375,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option was granted on January 8, 2026. The 375,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on January 8, 2027 and as to the remaining 75% of the shares in equal monthly installments thereafter through January 8, 2030.

Search

News categories